Loading

Cell View

Cell Information

  PDX metastatic renal cell carcinoma

Overall DesignIn order to identify successful clonal propagation from patient to PDX samples and understand pathogenesis from primary to metastatic RCC, we performed whole-exome sequencing (WES, n=4) and matched aCGH (n=4) on bulk tumor samples. And we utilized single-cell RNA sequencing (scRNA-seq) to model and dissect functional heterogeneity acroass primary and metastatic RCC tumors. We checked whether of capturing live one cell, not more cells, in microfluidics by fluorescent microscopic observation. To construct RNA sequencing libraries, we performed further quality controls including adequate quantities and qualities of amplified transcriptomes respectively from single cells. Tumor cells from the parental mRCC (n=34), PDX-mRCC (n=36) and PDX-pRCC (n=46) were finally analyzed in this study after filtering out poor quality cells.
SummaryClear cell renal cell carcinoma (ccRCC) initiated from the renal epithelium is the most prevalent histological type of adult kidney cancers. Dissecting intratumoral heterogeneity (ITH) of ccRCC has leveraged to extend our knowledge on how primary tumors harboring driver mutations evolve and spread to other sites. The cellular fractions within and across the primary (pRCC) and metastatic RCC (mRCC) are heterogeneous in both their genetic and biological features determining the variability in clinical aggressiveness and sensitivity to the therapy. To achieve sustainable therapeutic benefit with targeted agents in mRCC, the effective target should focus on signaling pathways that are related to driver mutations occurred early in the clonal evolution of the disease and thus should be common to primary tumor and metastatic sites. Considering that extensive genetic heterogeneity may result in drug response variability among patients and treatment resistance, the tailored strategies for metastatic RCC is urgently needed. Here, we analyze single-cell RNA-seq (scRNA-seq) data from a matched primary RCC (pRCC) and lung metastasis (mRCC) to dissect ITH at the highest resolution to date with the objective of discovering the better therapeutic regimen.
Dataset viewGSE73121
PMID27139883

Samples in PDX metastatic renal cell carcinoma

Displaying 21-30 of 36 results.
SeriesSampleInstrumentOrganismTitleCell Source
GSE73121GSM1887236Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_68PDX metastatic renal cell carcinoma
GSE73121GSM1887237Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_69PDX metastatic renal cell carcinoma
GSE73121GSM1887238Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_70PDX metastatic renal cell carcinoma
GSE73121GSM1887239Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_77PDX metastatic renal cell carcinoma
GSE73121GSM1887240Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_79PDX metastatic renal cell carcinoma
GSE73121GSM1887241Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_80PDX metastatic renal cell carcinoma
GSE73121GSM1887242Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_81PDX metastatic renal cell carcinoma
GSE73121GSM1887243Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_86PDX metastatic renal cell carcinoma
GSE73121GSM1887244Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_87PDX metastatic renal cell carcinoma
GSE73121GSM1887245Illumina HiSeq 2500Homo sapiensPDX_mRCC_SC_88PDX metastatic renal cell carcinoma

Gene rank in PDX metastatic renal cell carcinoma

Displaying 151-160 of 18370 results.
Rank orderGene SymbolEnsembl ID
151RPLP2ENSG00000177600
152TBCAENSG00000171530
153ACTG1ENSG00000184009
154PPIBENSG00000166794
155COX7CENSG00000127184
156RPSAENSG00000168028
157CYCSENSG00000172115
158COX7A2ENSG00000112695
159LDHAENSG00000134333
160RPL12ENSG00000197958